Our standard Chipcytometry panel (CD3, CD4, CD8, CD14, CD19, CD24, CD27, CD38, CD45RA, CD56, and HLA-DR) revealed a disproportionately high percentage of CD19+ B cells (84%) raising the suspicion of B cell lymphoma. The gene discussed is CD19; the disease is B-cell non-Hodgkin lymphoma.